About Hualan Biological Engineering, Inc. Company

The company was founded in 1992 for “gratitude, service, and return of love”. The company has long donated to welfare homes, nursing homes, hemophilia patients, and poor university students. Faced with sudden major disasters and epidemics, the company actively invests in relief, carries out corporate social responsibility through practical actions, and has been awarded the China Charity Award by the Ministry of Civil Affairs. The company is a national high-tech enterprise engaged in R&D, production and sales of blood products, vaccines and genetic engineering products. The company's business includes three types of business: research and development and production of blood products, vaccine products, innovative drugs and biosimilar drugs. The company's main products: human blood albumin, intravenous human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies patient immunoglobulin, tetanus human immunoglobulin, human coagulation factor VIII, human prothrombin complex, human fibrinogen, human fibrin gel, topical freeze-dried human thrombin, influenza virus lytic vaccine, influenza virus lysis vaccine, ACYW135 group meningococcal polysaccharide vaccine, recombinant hepatitis B vaccine (Hanson vaccine) yeast), group A group C meningococcal polysaccharide vaccine, quadrivalent influenza virus lysis vaccine, freeze-dried for human use Rabies vaccine (Vero cell), adsorbed tetanus vaccine. Corporate honors: National certified enterprise technology center title, national key new product certificate, Ukrainian GMP certification, etc.